CBTN Executive Director; Director of Operations and Strategic Planning
Center for Data Driven Discovery in Biomedicine
Jena Lilly is the Director of Operations and Strategic Planning for the Center for Data Driven Discovery in Biomedicine. Currently, she leads a team of over 30 people in support of international pediatric oncology research consortiums which combined, include over 25 pediatric hospitals. She is also responsible for the overall operations, strategy and innovation planning and execution for the D3b Center.
Prior to joining CHOP in June of 2008, Jena worked in a developmental biology lab at ASU as well as the nucleic acid facility at Thomas Jefferson University. She also worked for Merck & Co., Inc. as a clinical researcher.
Jena earned a BS in Biology from Arizona State University in Tempe, AZ before completing an MS in Project Management from Drexel University in Philadelphia, PA. She has also earned a certificate from The Leadership Edge Program at The Wharton School of the University of Pennsylvania. Jena is committed to finding new treatments and cures for children with cancer and rare diseases.
Children’s Hospital of Philadelphia
Whole Genome Sequencing and RNA Sequencing of the CBTN Bank for the Pediatric Brain Tumor Atlas
Research into adult cancer has benefited greatly from large scale genomic research. Until now due to the limited resources and availability pediatric brain tumors have not been part of large-scale genomic generation efforts. The CBTN aims to create a comprehensive genomic atlas for use by researchers worldwide to unlock how brain tumors develop, grow, survive, and how they can be treated and cured.
Craniopharyngioma, Medulloblastoma, HGG, (AT/RT), LGG, Ependymoma, Ganglioglioma, DNET, Choroid plexus tumors, Meningioma, DIPG, Oligodendroglioma, Schwannoma, Germinoma, Choroid Plexus Tumors, Subependymal Giant cell Astrocytoma, NGGCTs